Alpha Tau Medical DRTS
NASDAQ DRTS
$13.38 +0.02 (+0.15%)
At close: Nov 13, 2026 · 4:00 PM EST

Alpha Tau Medical (DRTS) Current Deferred Revenue (2026)

Updated

Alpha Tau Medical (DRTS) recorded Current Deferred Revenue of $18.88 million in Q2 2026.

Analysis

Alpha Tau Medical (DRTS) Current Deferred Revenue (2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 259.44 Bn 236.08 Bn 5.13 Bn
2 Abbott Laboratories 187.98 Bn 162.45 Bn 7.39 Bn
3 Danaher 163.91 Bn 143.58 Bn 3.84 Bn
4 Intuitive Surgical 153.75 Bn 134.17 Bn 2.08 Bn
5 Medtronic 131.67 Bn 97.80 Bn 6.34 Bn
6 Stryker 117.84 Bn 104.03 Bn 4.25 Bn
7 Boston Scientific 64.27 Bn 59.95 Bn 3.43 Bn
8 Edwards Lifesciences 61.69 Bn 45.00 Bn 1.35 Bn
9 Medline 51.94 Bn 49.07 Bn 1.93 Bn
10 Alpha Tau Medical 1.18 Bn 1.07 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 18.88 Mn
API Access

Alpha Tau Medical Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=DRTS&period=max&api_key=YOUR_API_KEY